|
Cold Agglutinin Disease: Clinical Challenges and Therapeutic Strategies |
04/04/2025 - 8:00am to 9:00am EDT |
|
The Evolving Role of Bispecific Antibody Therapy in Relapsed or Refractory Follicular Lymphoma |
04/11/2025 - 8:00am to 9:00am EDT |
|
Mantle Cell Lymphoma |
04/18/2025 - 8:00am to 9:00am EDT |
|
Integrating PARP Inhibitors for the Treatment of Metastatic Prostate Cancer: Optimizing Personalized Care in the VHA and Community Health Care Systems |
04/25/2025 - 8:00am to 9:00am EDT |
|
Systemic Mastocytosis |
05/09/2025 - 8:00am to 9:00am EDT |
|
Testicular Myeloid Sarcoma |
05/16/2025 - 8:00am to 9:00am EDT |
|
Adopting Innovation in Bladder Cancer: Aligning The Evidence on Antibody–Drug Conjugates to Inform Treatment Decisions |
05/23/2025 - 8:00am to 9:00am EDT |
|
Pride Month Update: Advancing Equitable Quality in Oncology for LGBTQ+ Patients and their Families |
06/06/2025 - 8:00am to 9:00am EDT |
|
Prostate Cancer: mCSPC with DIC |
06/13/2025 - 7:47am EDT |
|
Myelodysplastic Syndrome 2025 - Past, Present and Future |
06/20/2025 - 8:00am to 9:00am EDT |
Facebook
X
LinkedIn
Forward